As the editors seek to diversify the journal, book review editors from non-Anglo-North American perspectives are wanted for SHAD. The book review editor will help manage the flow of books and reviews, including identifying titles for review, populating a list of books, securing appropriate reviewers, and overseeing the timely completion of reviews.
Inquiries should be received by September 6, 2019. You can see the full request here.
Describe your book in terms your bartender could understand.
Strange Trips is about “dangerous drugs and magic bullets,” terms that many of us have heard and used. The book investigates how and why these labels (may) change over time. Drugs and pharmaceuticals are far from fixed entities that exist in hermetically sealed bubbles! So I use a number of substances (such as heroin, LSD, cannabis, and others) to challenge the idea that scientific and medical understandings alone determine perceptions of drugs in the modern era. And I make the case that a complex negotiation is happening between medico-scientific knowledge and culture.
In 2019, I feel like we’re operating in an environment where drug policies and regulations are more fluid than ever before. At least as far as I can remember. Strange Trips offers a background for discussions surrounding medical cannabis or the opioid crisis in the present.
What do you think a bunch of alcohol and drug historians might find particularly interesting about your book?
I don’t narrate a linear history of a single substance. Instead, I spotlight several different drugs and put them in dialogue with each other. I definitely enjoy singular biographies of substances or pharmaceuticals, don’t get me wrong. But I reckon that blended analyses will be of value to the historiography as well.
Now that the hard part is over, what is the thing YOU find most interesting about your book?
The character studies. The subtler moments. The finer details. Also: playing with the content and the form of an academic book. Y’know, we have to take pleasure in the writing process.
Another thing I find intriguing about the book at this moment is the evolution: what was cut and why. Where (and who) I was when I started, versus where (and who) I am now. Silly, but true.
Every research project leaves some stones unturned. What stone are you most curious to see turned over soon?
For sure. There are always more avenues to explore. I look forward to seeing the results of various ongoing projects out there: pharmaceuticals and sexual politics (think LSD and conversion therapy); so-called lifestyle drugs; and stimulant use in Asia. I try and keep my finger on the pulse. This might also be a useful opportunity to invite submissions to Social History of Alcohol and Drugs: An Interdisciplinary Journal, which just moved to the University of Chicago Press.
BONUS QUESTION: In an audio version of the book, who should provide the narration?
That’s a difficult one to answer. For the English language version, I’ll pick two: Dame Judi Dench and Peter Capaldi. I’d have to think more carefully about other languages.
David Herzberg, Nancy Campbell, and Lucas Richert (L-R), the co-editors of the Social History of Alcohol and Drugs journal
In January 2018, Nancy Campbell, David Herzberg, and Lucas Richert assumed responsibility for Social History of Drugs and Alcohol: An Interdisciplinary Journal. They took on the role of co-editors in chief and began planning for the future. In April, the ADHS signed an agreement with University of Chicago Press.
SHAD’s new co-editors, L-R: David Herzberg, Nancy Campbell, and Lucas Richert
1.) Tell us about your history as a scholar. What got you interested in alcohol and drug history?
Nancy: As the daughter and grand-daughter of small-town doctors, I was fascinated by the drug room and amassed a large collection of pharmaceutical giveaways. I was struck by how dismissive people were toward “druggies,” so at a tender age, I announced my intention to write a history of drugs. I’m just sticking to the plan.
Luc: I didn’t have a plan. Far from it. But I did figure out that I wanted to focus on the field of history in my third year of undergraduate. I started scheming and scrambling after I finished up at the University of Saskatchewan – and then I traveled to Edinburgh and London for graduate school. Early on, the American pharmaceutical policy grabbed my attention for a number of reasons; ultimately, this seemed a useful way of understanding the Reagan administration in the 1980s.
David: One of my closest friends in college had a very severe anxiety disorder. He was a very charismatic guy and liked to hold court and hold forth while medicating himself thoroughly with the one drug that he said eased his mind, alcohol. A favorite subject of his was Big Pharma medical journal ads. He had somehow come into possession of a huge stack of old journals, and he would flip through the images of smilingly healed people, deconstructing them freestyle, brilliantly but also bitterly–those drugs had let him down, but there they still were, mocking him with their shiny and, to him, fake promises. It stuck with me, this acute, intense version of consumer culture promises and human realities. My friend died while I was in grad school, making the questions more urgent right around when it was time to pick a dissertation topic.
The conversation took place on June 8, 2018. It has been edited for brevity and clarity.
Stephanie and I sat down to talk in the Purdue Memorial Union’s coffee shop early on a Friday morning and immediately realized we couldn’t stay. There was far too much activity. It was incredibly loud. “I know another spot,” she told me.
Five minutes later, we found ourselves in an adjacent building. Stephanie was sipping coffee, as was I. We were set. Except not. A speaker on the floor beside us unexpectedly started up and the Kongos’ song “Come with me now” boomed. So we swiftly collected our belongings and moved across the room to a quieter table.
Second, the co-editors of SHAD just signed a five-year agreement with the University of Chicago Press, beginning with the 2019 volume of the journal. ADHS President Dr. Timothy Hickman celebrated the news in an email, stating that “this is a fantastic deal for the society. Of greatest interest to those of you who have published in the journal or are considering it, our reach will grow dramatically. We will be bundled in with other U. of Chicago journals and will be part of their institutional subscription package. That means we will become available in hundreds of libraries and research institutes all over the world where we had no presence before.
“It also means that the entire run of the journal will be easily available electronically and that the submission and review process will be brought up to date. Submission will be centralized, and reviews assigned via an on-line submission system. The new system will push the journal to an entirely new level, which I hope will encourage even more of you to submit. The society will also benefit from a very lucrative financial arrangement with the press.
“We will also be able to bring our membership and subscription practices up to date. The U. of Chicago Press will manage subscriptions, so please watch out for a renewal e-mail from them in the future.”
But that’s not all! Things just seem to be getting more exciting for ADHS: our 2019 conference will take us to Shanghai!
Editor’s Note: Today’s post comes from Lucas Richert and James H. Mills, professors at the University of Strathclyde in Glasgow and the organizers of the Cannabis: Global Histories conference, held April 19-20, 2018. They discuss the importance of developing a “big picture narrative” about the history of cannabis, and, as countries across the world reconsider marijuana laws, emphasize the need for this global approach. Enjoy!
Over the past decade governments in Uruguay, Portugal and the USA have made significant alterations to cannabis policies and other countries, such as Canada, have committed to major change this year. In 2018, Canada will be the first G7 country committed to ending cannabis prohibition at the federal level.
Ninety years after the UK imposed its own 1928 Coca Leaves and Indian Hemp Regulations, the Cannabis: Global Histories symposium at the University of Strathclyde, Glasgow addressed a range of historical questions about the origins of attitudes towards, policies on, and markets for cannabis substances. After all, by understanding how countries have come to the laws and control mechanisms that they currently deploy, and the reasons that consumers and suppliers have often proven to be so resistant to them, contemporary positions and future directions can be clearer, better-informed and free of the prejudices of the past.